Chung‐Min Yeh

588 total citations
32 papers, 441 citations indexed

About

Chung‐Min Yeh is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Chung‐Min Yeh has authored 32 papers receiving a total of 441 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 8 papers in Oncology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Chung‐Min Yeh's work include Cancer-related gene regulation (7 papers), Genetic Syndromes and Imprinting (5 papers) and Kruppel-like factors research (5 papers). Chung‐Min Yeh is often cited by papers focused on Cancer-related gene regulation (7 papers), Genetic Syndromes and Imprinting (5 papers) and Kruppel-like factors research (5 papers). Chung‐Min Yeh collaborates with scholars based in Taiwan, Vietnam and Singapore. Chung‐Min Yeh's co-authors include Kun‐Tu Yeh, Shun‐Fa Yang, Wen‐Wei Sung, Chih‐Jung Chen, Yueh‐Min Lin, Yih‐Shou Hsieh, Shu‐Hui Lin, Jan‐Gowth Chang, Nicholas C. Hsu and Pei‐Ru Wu and has published in prestigious journals such as PLoS ONE, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Chung‐Min Yeh

30 papers receiving 438 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chung‐Min Yeh Taiwan 13 310 134 117 42 40 32 441
Kinga A. Kocemba‐Pilarczyk Poland 11 390 1.3× 156 1.2× 170 1.5× 28 0.7× 26 0.7× 24 570
Joanne Berry United Kingdom 4 415 1.3× 99 0.7× 100 0.9× 34 0.8× 27 0.7× 4 516
Shinji Oie Japan 12 315 1.0× 88 0.7× 140 1.2× 39 0.9× 32 0.8× 22 515
Mitsuhiko Ogaki Japan 8 221 0.7× 131 1.0× 123 1.1× 37 0.9× 25 0.6× 9 370
Mitsuhiro Hishida Japan 12 309 1.0× 152 1.1× 91 0.8× 82 2.0× 44 1.1× 23 484
Ihor Yakymovych Sweden 11 381 1.2× 67 0.5× 105 0.9× 33 0.8× 27 0.7× 16 475
Feng Xing China 12 492 1.6× 124 0.9× 199 1.7× 40 1.0× 62 1.6× 20 644
Xi Cheng China 12 348 1.1× 232 1.7× 143 1.2× 56 1.3× 23 0.6× 18 531
Maria Luisa Nicolosi Italy 14 319 1.0× 160 1.2× 184 1.6× 34 0.8× 48 1.2× 14 606
Qichao Ni China 14 394 1.3× 184 1.4× 149 1.3× 50 1.2× 25 0.6× 35 567

Countries citing papers authored by Chung‐Min Yeh

Since Specialization
Citations

This map shows the geographic impact of Chung‐Min Yeh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chung‐Min Yeh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chung‐Min Yeh more than expected).

Fields of papers citing papers by Chung‐Min Yeh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chung‐Min Yeh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chung‐Min Yeh. The network helps show where Chung‐Min Yeh may publish in the future.

Co-authorship network of co-authors of Chung‐Min Yeh

This figure shows the co-authorship network connecting the top 25 collaborators of Chung‐Min Yeh. A scholar is included among the top collaborators of Chung‐Min Yeh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chung‐Min Yeh. Chung‐Min Yeh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Li, Chi‐Cheng, Bruce Chi‐Kang Tsai, Ming‐Cheng Chen, et al.. (2024). Tannic Acid Impedes the Proliferation of Bladder Cancer Cells by Elevating Mitochondrial Pathways of Apoptosis. Cell Biochemistry and Biophysics. 82(2). 1325–1333. 2 indexed citations
3.
Chen, Ming-Cheng, Yi‐Sheng Liu, Chung‐Min Yeh, et al.. (2024). Sensitization of hepatocellular carcinoma cells to HDACi is regulated through hsa-miR-342-5p/CFL1. Cancer Cell International. 24(1). 291–291. 1 indexed citations
4.
Velmurugan, Bharath Kumar, Chia‐Chieh Lin, Zuhair M. Mohammedsaleh, et al.. (2023). Prognostic and Clinical Implications of UNC13C expression in Hepatocellular Carcinoma Patients. International Journal of Medical Sciences. 20(9). 1235–1239. 1 indexed citations
5.
Chen, Ming‐Cheng, Chia‐Hua Kuo, Tzu‐Ching Shih, et al.. (2022). Daidzein Synergizes with Gefitinib to Induce ROS/JNK/c-Jun Activation and Inhibit EGFR-STAT/AKT/ERK Pathways to enhance Lung Adenocarcinoma cells chemosensitivity. International Journal of Biological Sciences. 18(9). 3636–3652. 27 indexed citations
6.
Yeh, Chung‐Min, et al.. (2021). Over-expression of CEP55 Predicts Favorable Prognosis in Colorectal Cancer Patients With Lymph Node Involvement. Anticancer Research. 41(1). 543–547. 9 indexed citations
7.
Yeh, Chung‐Min, et al.. (2021). High Expression of MTA1 Predicts Unfavorable Survival in Patients With Oral Squamous Cell Carcinoma. In Vivo. 35(4). 2363–2368. 4 indexed citations
8.
Velmurugan, Bharath Kumar, Yueh‐Min Lin, B. Mahalakshmi, et al.. (2020). Increased Expression of p-GSK3β Predicts Poor Survival in T –III/IV Stage OSCC Patients. In Vivo. 34(4). 1805–1809. 2 indexed citations
9.
Chen, Mei‐Ling, Chung‐Min Yeh, Sung‐Lang Chen, et al.. (2019). High SPOCK1 Expression Is Associated with Advanced Stage, T Value, and Gleason Grade in Prostate Cancer. Medicina. 55(7). 343–343. 10 indexed citations
10.
Chang, Chun‐Chi, Wen‐Wei Sung, Hui‐Ting Hsu, et al.. (2018). Validation of EGFL6 expression as a prognostic marker in patients with lung adenocarcinoma in Taiwan: a retrospective study. BMJ Open. 8(6). e021385–e021385. 10 indexed citations
11.
Yeh, Chung‐Min, Shu‐Hui Lin, Jian‐Liang Chou, et al.. (2016). Epigenetic silencing of the NR4A3 tumor suppressor, by aberrant JAK/STAT signaling, predicts prognosis in gastric cancer. Scientific Reports. 6(1). 31690–31690. 41 indexed citations
12.
Yeh, Chung‐Min, Wen‐Wei Sung, Hung‐Wen Lai, et al.. (2015). Opposing prognostic roles of nuclear and cytoplasmic RACGAP1 expression in colorectal cancer patients. Human Pathology. 47(1). 45–51. 16 indexed citations
13.
Lin, Shu‐Hui, Chung‐Min Yeh, Ming‐Ju Hsieh, et al.. (2015). Low cytoplasmic casein kinase 1 epsilon expression predicts poor prognosis in patients with hepatocellular carcinoma. Tumor Biology. 37(3). 3997–4005. 8 indexed citations
14.
Lee, W. Robert, Shing‐Chuan Shen, Pei‐Ru Wu, et al.. (2015). CSE1L Links cAMP/PKA and Ras/ERK pathways and regulates the expressions and phosphorylations of ERK1/2, CREB, and MITF in melanoma cells. Molecular Carcinogenesis. 55(11). 1542–1552. 23 indexed citations
15.
Hwang, Jau‐Chung, Wen‐Wei Sung, Hung‐Pin Tu, et al.. (2015). The Overexpression of FEN1 and RAD54B May Act as Independent Prognostic Factors of Lung Adenocarcinoma. PLoS ONE. 10(10). e0139435–e0139435. 27 indexed citations
16.
Lin, Shu‐Hui, Yueh‐Min Lin, Chung‐Min Yeh, et al.. (2014). Casein Kinase 1 Epsilon Expression Predicts Poorer Prognosis in Low T-Stage Oral Cancer Patients. International Journal of Molecular Sciences. 15(2). 2876–2891. 28 indexed citations
17.
Hsu, Li‐Sung, et al.. (2013). Positive nuclear expression of KLF8 might be correlated with shorter survival in gastric adenocarcinoma. Annals of Diagnostic Pathology. 18(2). 74–77. 15 indexed citations
18.
Chu, Pei‐Yi, Chung‐Min Yeh, Kun‐Tu Yeh, & Liu Ch. (2012). Tubulopapillary Carcinoma-A Frequent Over-Diagnosed Entity in Canine Mammary Gland Tumors. 38(2). 67–74.
19.
Chu, Pei‐Yi, Chung‐Min Yeh, Nicholas C. Hsu, et al.. (2010). Epigenetic alteration of the SOCS1 gene in hepatocellular carcinoma. Swiss Medical Weekly. 140. w13065–w13065. 37 indexed citations
20.
Yang, Shun‐Fa, Kun‐Tu Yeh, Chung‐Min Yeh, et al.. (2006). Relationships between the level of matrix metalloproteinase-2 and tumor size of breast cancer. Clinica Chimica Acta. 371(1-2). 92–96. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026